Abstract
BackgroundThe optimal number of neoadjuvant chemotherapy cycles in patients with advanced ovarian cancer is still disputed.ObjectiveTo evaluate the impact of the number of neoadjuvant chemotherapy cycles and role of optimal...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Paper Title
Journal
Date
